Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cell-mediated Immune Responses

Cell-mediated Immune Responses

T Cell Types and Functions

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

Encephalitis ll: Pathophysiology

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...

Multiple Sclerosis l: Introduction

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

Myasthenia Gravis ll: Pathophysiology

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Disease outcomes with ublituximab in treatment-naïve participants: subpopulation analyses of the phase 3 ULTIMATE I and II studies in participants with relapsing multiple sclerosis.

Frontiers in immunology·2026

Same author

Plasma Proteomic Networks Reveal Shared Biology with Brain Linked to Alzheimer's Disease Pathology.

medRxiv : the preprint server for health sciences·2026

Same author

Correction: Working to Increase Stability through Exercise (WISE): screening, recruitment, and baseline characteristics.

Trials·2026

Same author

CSF Proteomics and Machine Learning Reveal Distinct Stages Across the Alzheimer's Disease Continuum.

medRxiv : the preprint server for health sciences·2025

Same author

Cerebrospinal fluid proteomics for predictive assessment of Alzheimer's Disease risk.

medRxiv : the preprint server for health sciences·2025

Same author

Multi-scale integration of human brain vascular and CSF proteomes reveals biomarkers of cerebral amyloid angiopathy linked to Alzheimer's disease risk.

medRxiv : the preprint server for health sciences·2025

Search research articles

Related Experiment Video

Updated: Jul 11, 2026

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices

Published on: February 5, 2015

Immunopathology of multiple sclerosis.

¹Multiple Sclerosis Clinic of Central Texas, 7200 Wyoming Springs Dr., Suite 1100, Round Rock, TX 78681, USA. FoxTex@aol.com

|December 30, 2004

Summary

Multiple sclerosis (MS) involves CNS inflammation, demyelination, and axon loss, driven by T(H)1 T cells. New therapies are needed to promote remyelination and neuroprotection, addressing irreversible axon damage and long-term disability.

Area of Science:

Neuroimmunology
Central Nervous System (CNS) Disorders
Autoimmune Diseases

Background:

Multiple sclerosis (MS) is an immune-mediated CNS disease.
Characterized by inflammation, demyelination, and axon loss.
Inflammation is linked to an overactive pro-inflammatory T(H)1 T cell profile.

Purpose of the Study:

To summarize the pathological hallmarks of MS.
To highlight the limitations of current FDA-approved treatments.
To identify the need for novel therapeutic strategies.

Main Methods:

Review of existing literature on MS pathogenesis.
Analysis of the mechanisms of inflammation, demyelination, and axon loss.
Evaluation of the efficacy of current MS therapies.

More Related Videos

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Published on: February 23, 2015

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis

Published on: December 1, 2023

Related Experiment Videos

Last Updated: Jul 11, 2026

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices

Published on: February 5, 2015

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Published on: February 23, 2015

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis

Published on: December 1, 2023

Main Results:

MS involves inflammation, demyelination, and early axon loss.
Current treatments are most effective during the inflammatory phase.
Axon loss is irreversible and contributes to long-term disability.

Conclusions:

Existing MS therapies primarily target inflammation.
There is a critical need for therapies promoting remyelination.
Neuroprotective strategies are essential to prevent irreversible axon damage and disability in MS.